Germany Approves Third Trial of IDT Biologika Covid-19 Vaccine

Russia and China have already deployed shots before full efficacy trials have been concluded, and front-runners from Pfizer, Moderna, and AstraZeneca are likely to have final-stage trial results before year-end.

Read also: How Thoughtful: Putin Offers Free Coronavirus Vaccine to UN Workers

Germany has awarded vaccine makers BioNTech and CureVac €627 million ($734.78 million) to help speed up work on their Covid-19 shots and expand German production capacity. It is also in talks with IDT about providing funding. ($1 = 0.8533 euros)

(Writer: Caroline Copley | Editor: Michelle Adair)

Source: https://www.reuters.com/article/health-coronavirus-germany-vaccine-idUSL8N2GT14M